SCHOLAR ROCK HLDG CORP's ticker is SRRK and the CUSIP is 80706P103. A total of 102 filers reported holding SCHOLAR ROCK HLDG CORP in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $76,822 | -0.3% | 10,820 | +5.9% | 0.00% | 0.0% |
Q2 2023 | $77,066 | -14.2% | 10,221 | -9.0% | 0.00% | 0.0% |
Q1 2023 | $89,816 | -9.2% | 11,227 | +2.7% | 0.00% | 0.0% |
Q4 2022 | $98,898 | +35.5% | 10,928 | +3.9% | 0.00% | 0.0% |
Q3 2022 | $73,000 | -63.7% | 10,522 | +72.7% | 0.00% | -50.0% |
Q3 2021 | $201,000 | -42.1% | 6,093 | -11.1% | 0.00% | -33.3% |
Q1 2021 | $347,000 | +18.0% | 6,855 | +13.0% | 0.00% | 0.0% |
Q4 2020 | $294,000 | – | 6,064 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Artal Group S.A. | 2,450,000 | $31,581,000 | 1.32% |
Logos Global Management LP | 675,000 | $8,701,000 | 1.13% |
Samsara BioCapital, LLC | 339,611 | $4,378,000 | 1.10% |
Redmile Group, LLC | 2,407,326 | $31,030,000 | 0.97% |
Bellevue Group AG | 2,184,425 | $28,157,000 | 0.33% |
Frazier Life Sciences Management, L.P. | 156,000 | $2,011,000 | 0.17% |
Atom Investors LP | 25,839 | $333,000 | 0.16% |
GSA CAPITAL PARTNERS LLP | 32,010 | $413,000 | 0.06% |
Tekla Capital Management LLC | 108,833 | $1,403,000 | 0.05% |
Virtus ETF Advisers LLC | 6,212 | $80,000 | 0.04% |